The core activity of Prosalix AG is the development and research of medical products, in particular citrate-based therapies, for the treatment of kidney and metabolic diseases. The company focuses on developing innovative solutions for nephrology, urology and endocrinology, with the goal of improving the quality of life for patients.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Innovative prescription medication in stickpacks containing citrates, for treatment and prevention in nephrology, urology and endocrinology; intended to reduce catheter encrustation, prevent kidney stones and support metabolic balance.
Research and development of citrate-based therapies
Research and development of citrate-based Therapies for kidney and metabolic health, including preclinical studies and clinical testing with Pro24c.
Knowledge
No knowledge articles yet
Once Prosalix AG has claimed this profile, we'll publish editorial articles and case studies here together.